The Company Flexion Therapeutics Inc. (United States), is listed on Nasdaq with a market cap of $ 1.26 Billion, having an equity of $ -82.38 Millions.
With a total of 257 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.
In the last 12 months the Company had a revenue of $ 100.40 Millions, which generated a loss in the amount of $ -100.72 Millions.
As for its main indicators, the Company has a P/E ratio of -12.52, a P/BV ratio of -15.31 and in the last 12 months the dividend yield of FLXN was at 0.57%.
The Company is traded internationally through the ticker FLXN.